Bladder Cancer

Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex. June 11, 2021

Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. June 11, 2021

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions. June 10, 2021

Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer. June 10, 2021

Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study. June 9, 2021

Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG. June 9, 2021

Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol. June 7, 2021

Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma. June 7, 2021

A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree. June 4, 2021

Immune Checkpoint Inhibition in Advanced Bladder and Kidney Cancer: Responses and Further Management. June 4, 2021

Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer. June 3, 2021

Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer. June 3, 2021

Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopy. June 2, 2021

Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life? June 2, 2021

Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy. June 1, 2021

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS). June 1, 2021

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis. May 31, 2021

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study. May 31, 2021

Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy. May 31, 2021

The prognostic effect of metastasis patterns on overall survival in patients with distant metastatic bladder cancer: a SEER population-based analysis. May 28, 2021

Page 1 of 396